1. Homepage
  2. Equities
  3. Canada
  4. Toronto Stock Exchange
  5. BELLUS Health Inc
  6. News
  7. Press Releases
       CA07987C1059

BELLUS HEALTH INC

Delayed Toronto Stock Exchange  -  08/30 04:00:00 pm EDT
9.340 CAD   +6.02%
05/11BELLUS : Q1 Earnings Snapshot
AQ
05/11Bellus Health Reports Q1 Net Loss of US$14.4 Million, Provides Update
MT
05/11BELLUS Health Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
SummaryChartsNewsRatingsCalendarCompany 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Communiqués de presse de la société BELLUS HEALTH INC
05/11BELLUS : Q1 Earnings Snapshot
AQ
05/11BELLUS Health Reports First Quarter 2022 Financial Results and Business Highlights
BU
05/02BELLUS HEALTH : to Present Late-Breaking Clinical Data from the Phase 2b SOOTHE Trial of B..
PU
05/02BELLUS Health to Present Late-Breaking Clinical Data from the Phase 2b SOOTHE Trial of ..
BU
04/25BELLUS HEALTH : to Participate in Multiple Upcoming Investor Conferences - Form 6-K
PU
04/25BELLUS Health to Participate in Multiple Upcoming Investor Conferences
BU
04/07BELLUS HEALTH : NOTICE OF ANNUAL MEETING OF SHAREHOLDERS - Form 6-K
PU
04/06BELLUS HEALTH : Form of Proxy – Annual General Meeting
PU
04/05BELLUS HEALTH : MANAGEMENT'S DISCUSSION AND ANALYSIS - Form 6-K
PU
04/01BELLUS HEALTH : Corporate Presentation – April 2022
PU
03/04BELLUS HEALTH : Notice of the Meeting and Record Date - Form 6-K
PU
03/01BELLUS HEALTH : Corporate Presentation – March 2022
PU
03/01BELLUS HEALTH : to Participate in the Cowen & Co. 42nd Annual Health Care Conference - For..
PU
03/01BELLUS Health to Participate in the Cowen & Co. 42nd Annual Health Care Conference
BU
02/23BELLUS : Q4 Earnings Snapshot
AQ
02/23BELLUS HEALTH : Annual Report by Canadian Issuer (Form 40-F)
PU
02/23BELLUS HEALTH : Reports Year 2021 Financial Results and Business Highlights - Form 6-K
PU
02/23BELLUS Health Reports Year 2021 Financial Results and Business Highlights
BU
02/11BELLUS HEALTH : Corporate Presentation – February 2022
PU
2021BELLUS HEALTH : Corporate Presentation – December 2021
PU
2021BELLUS HEALTH : Closes US$200 Million Public Offering of Common Shares in Canada and the U..
PU
2021BELLUS Health Closes US$200 Million Public Offering of Common Shares in Canada and the ..
BU
2021BELLUS HEALTH : Announces Pricing of US$200 Million Public Offering in Canada and the Unit..
PU
2021BELLUS Health Announces Pricing of US$200 Million Public Offering in Canada and the Uni..
BU
2021BELLUS HEALTH : Announces the Launch of a Public Offering of Common Shares in Canada and t..
PU
2021BELLUS Health Announces the Launch of a Public Offering of Common Shares in Canada and ..
BU
2021IIROC Trade Resumption - BLU
AQ
2021IIROC Trading Halt - BLU
AQ
2021BELLUS HEALTH : Announces Positive Topline Results from its Phase 2b SOOTHE Trial of BLU-5..
PU
2021BELLUS Health Announces Positive Topline Results from its Phase 2b SOOTHE Trial of BLU-..
BU
2021BELLUS : Q3 Earnings Snapshot
AQ
2021BELLUS Health Reports Third Quarter 2021 Financial Results and Business Highlights - Fo..
PU
2021BELLUS Health Reports Third Quarter 2021 Financial Results and Business Highlights
BU
2021BELLUS Health to Participate in Two Upcoming Healthcare Investor Conferences - Form 6-K
PU
2021BELLUS Health to Participate in Two Upcoming Healthcare Investor Conferences
BU
2021Corporate Presentation – November 2021
PU
2021BELLUS Health Convenes Virtual Analyst Event to Discuss the Chronic Cough Landscape and..
PU
2021BELLUS Health Convenes Virtual Analyst Event to Discuss the Chronic Cough Landscape and..
BU
2021BELLUS HEALTH : Announces Completion of Patient Enrollment in SOOTHE Phase 2b Trial for Re..
PU
2021BELLUS HEALTH : Announces Completion of Patient Enrollment in SOOTHE Phase 2b Trial for Re..
BU
2021BELLUS HEALTH : Announces Positive Interim Analysis from the Phase 2b SOOTHE Trial of BLU-..
PU
2021BELLUS HEALTH : Announces Positive Interim Analysis from the Phase 2b SOOTHE Trial of BLU-..
BU
2021BELLUS HEALTH : to Present at the H.C. Wainwright Global Investment Conference (Form 6-K)
PU
2021BELLUS HEALTH : to Present at the H.C. Wainwright Global Investment Conference
BU
2021BELLUS HEALTH : to Report Additional RELIEF Data in an Oral Presentation at the European R..
PU
2021BELLUS HEALTH : to Report Additional RELIEF Data in an Oral Presentation at the European R..
BU
2021BELLUS : Q2 Earnings Snapshot
AQ
2021BELLUS HEALTH : Condensed Consolidated Interim Statements of Loss and Other Comprehensive ..
PU
2021BELLUS HEALTH : Reports Second Quarter 2021 Financial Results and Business Highlights (For..
PU
2021BELLUS HEALTH : Reports Second Quarter 2021 Financial Results and Business Highlights
BU
2021BELLUS HEALTH : to Participate in the Jefferies Virtual Healthcare Conference (Form 6-K)
PU
2021BELLUS HEALTH : to Participate in the Jefferies Virtual Healthcare Conference
BU
2021BELLUS HEALTH : to Participate in the 2021 RBC Capital Markets Global Healthcare Conferenc..
PU
2021BELLUS HEALTH : Condensed Consolidated Interim Financial Statements (Unaudited) for the pe..
PU
2021BELLUS HEALTH : Ended quarter with US$81.9 million in cash, cash equivalents and short-ter..
PU
2021BELLUS HEALTH : to Participate in the 2021 RBC Capital Markets Global Healthcare Conferenc..
BU
2021BELLUS HEALTH : to Present at the American Thoracic Society 2021 International Conference ..
PU
2021BELLUS : Q1 Earnings Snapshot
AQ
2021BELLUS HEALTH : Reports First Quarter 2021 Financial Results and Business Highlights
BU
2021BELLUS HEALTH : to Present at the American Thoracic Society 2021 International Conference
BU
2021BELLUS HEALTH : to Present at the Bloom Burton & Co. Healthcare Investor Conference
BU
2021SHAREHOLDER ALERT : Robbins LLP Announces That BELLUS Health Inc. (BLU) is Being Sued for ..
BU
2021BELLUS HEALTH : Appoints William Mezzanotte, MD, MPH to its Board of Directors
BU
2021GLANCY PRONGAY & MURRAY LLP : a Leading Securities Fraud Law Firm, Announces Investigation..
BU
2021THE LAW OFFICES OF FRANK R. CRUZ : Announces Investigation of BELLUS Health Inc. (BLU) on ..
BU
2021INVESTOR ALERT : Law Offices of Howard G. Smith Announces Investigation of BELLUS Health I..
BU
2021BELLUS HEALTH : Reports Year 2020 Financial Results and Business Highlights
BU
2021BELLUS HEALTH : to Participate in Two Upcoming Healthcare Investor Conferences
BU
2021BELLUS HEALTH : IIROC Trade Resumption - BLU
AQ
2021BELLUS HEALTH : IIROC Trading Halt - BLU
AQ
2021BELLUS HEALTH : to Present at the Eleventh International Virtual Cough Symposium
BU
2020BELLUS HEALTH : Establishes At-the-Market Facility
BU
2020BELLUS HEALTH : Announces First Patient Dosed in its Phase 2 BLUEPRINT Trial of BLU-5937 f..
BU
2020BELLUS HEALTH : Announces First Patient Dosed in its Phase 2b SOOTHE Trial of BLU-5937 for..
BU
2020BELLUS HEALTH : Appoints Ramzi Benamar as Chief Financial Officer
BU
1  2  3Next
Upcoming event on BELLUS HEALTH INC